Tumorspheres derived from prostate cancer cells possess chemoresistant and cancer stem cell properties

Linlin Zhang, Min Jiao, Lei Li, Dapeng Wu, Kaijie Wu, Xiang Li, Guodong Zhu, Qiang Dang, Xinyang Wang, Jer Tsong Hsieh, Dalin He

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Purpose: Prostate cancer (PCa) becomes lethal when cancer cells develop into castration-resistant PCa, which remains incurable because of the poor understanding of their cell origin and characteristics. We aim to investigate the potential role of cancer stem cells (CSCs) in PCa progression. Methods: Human PCa cell lines (LNCaP, 22RV1, DU145 and PC-3) were plated in serum-free suspension culture system allowed for tumorsphere forming. To evaluate the CSC characteristics of tumorspheres, the self-renewal, chemoresistance, tumorigenicity of the PCa tumorsphere cells, and the expression levels of stemness-related proteins in the PCa tumorsphere cells were assessed, comparing with the parental adherent cells. Results: Tumorsphere cells from PCa cell lines displayed enhanced self-renewal, chemoresistance and tumor-initiating capacity when compared with the adherent cells. Additionally, these cells overexpressed CSC marker CD44. Also, the tumorsphere cells expressed high levels of "stemness" genes Gli1, ABCG2 and Bmi-1. Conclusions: Collectively, these data demonstrated that tumorspheres derived from PCa cells possess chemoresistant and CSC properties. Our study suggests that the identification of PCa CSCs could provide new insight into the lethal phenotype of PCa and therapeutic implications.

Original languageEnglish (US)
Pages (from-to)675-686
Number of pages12
JournalJournal of Cancer Research and Clinical Oncology
Volume138
Issue number4
DOIs
StatePublished - Apr 2012

Fingerprint

Neoplastic Stem Cells
Prostatic Neoplasms
Cell Line
Castration
Neoplasms
Suspensions
Phenotype

Keywords

  • Cancer stem cell
  • Chemoresistance
  • Prostate cancer
  • Stemness
  • Tumorsphere

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Tumorspheres derived from prostate cancer cells possess chemoresistant and cancer stem cell properties. / Zhang, Linlin; Jiao, Min; Li, Lei; Wu, Dapeng; Wu, Kaijie; Li, Xiang; Zhu, Guodong; Dang, Qiang; Wang, Xinyang; Hsieh, Jer Tsong; He, Dalin.

In: Journal of Cancer Research and Clinical Oncology, Vol. 138, No. 4, 04.2012, p. 675-686.

Research output: Contribution to journalArticle

Zhang, Linlin ; Jiao, Min ; Li, Lei ; Wu, Dapeng ; Wu, Kaijie ; Li, Xiang ; Zhu, Guodong ; Dang, Qiang ; Wang, Xinyang ; Hsieh, Jer Tsong ; He, Dalin. / Tumorspheres derived from prostate cancer cells possess chemoresistant and cancer stem cell properties. In: Journal of Cancer Research and Clinical Oncology. 2012 ; Vol. 138, No. 4. pp. 675-686.
@article{95e821e4d1824fcd8d2cff6cf17fbe16,
title = "Tumorspheres derived from prostate cancer cells possess chemoresistant and cancer stem cell properties",
abstract = "Purpose: Prostate cancer (PCa) becomes lethal when cancer cells develop into castration-resistant PCa, which remains incurable because of the poor understanding of their cell origin and characteristics. We aim to investigate the potential role of cancer stem cells (CSCs) in PCa progression. Methods: Human PCa cell lines (LNCaP, 22RV1, DU145 and PC-3) were plated in serum-free suspension culture system allowed for tumorsphere forming. To evaluate the CSC characteristics of tumorspheres, the self-renewal, chemoresistance, tumorigenicity of the PCa tumorsphere cells, and the expression levels of stemness-related proteins in the PCa tumorsphere cells were assessed, comparing with the parental adherent cells. Results: Tumorsphere cells from PCa cell lines displayed enhanced self-renewal, chemoresistance and tumor-initiating capacity when compared with the adherent cells. Additionally, these cells overexpressed CSC marker CD44. Also, the tumorsphere cells expressed high levels of {"}stemness{"} genes Gli1, ABCG2 and Bmi-1. Conclusions: Collectively, these data demonstrated that tumorspheres derived from PCa cells possess chemoresistant and CSC properties. Our study suggests that the identification of PCa CSCs could provide new insight into the lethal phenotype of PCa and therapeutic implications.",
keywords = "Cancer stem cell, Chemoresistance, Prostate cancer, Stemness, Tumorsphere",
author = "Linlin Zhang and Min Jiao and Lei Li and Dapeng Wu and Kaijie Wu and Xiang Li and Guodong Zhu and Qiang Dang and Xinyang Wang and Hsieh, {Jer Tsong} and Dalin He",
year = "2012",
month = "4",
doi = "10.1007/s00432-011-1146-2",
language = "English (US)",
volume = "138",
pages = "675--686",
journal = "Journal of Cancer Research and Clinical Oncology",
issn = "0171-5216",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Tumorspheres derived from prostate cancer cells possess chemoresistant and cancer stem cell properties

AU - Zhang, Linlin

AU - Jiao, Min

AU - Li, Lei

AU - Wu, Dapeng

AU - Wu, Kaijie

AU - Li, Xiang

AU - Zhu, Guodong

AU - Dang, Qiang

AU - Wang, Xinyang

AU - Hsieh, Jer Tsong

AU - He, Dalin

PY - 2012/4

Y1 - 2012/4

N2 - Purpose: Prostate cancer (PCa) becomes lethal when cancer cells develop into castration-resistant PCa, which remains incurable because of the poor understanding of their cell origin and characteristics. We aim to investigate the potential role of cancer stem cells (CSCs) in PCa progression. Methods: Human PCa cell lines (LNCaP, 22RV1, DU145 and PC-3) were plated in serum-free suspension culture system allowed for tumorsphere forming. To evaluate the CSC characteristics of tumorspheres, the self-renewal, chemoresistance, tumorigenicity of the PCa tumorsphere cells, and the expression levels of stemness-related proteins in the PCa tumorsphere cells were assessed, comparing with the parental adherent cells. Results: Tumorsphere cells from PCa cell lines displayed enhanced self-renewal, chemoresistance and tumor-initiating capacity when compared with the adherent cells. Additionally, these cells overexpressed CSC marker CD44. Also, the tumorsphere cells expressed high levels of "stemness" genes Gli1, ABCG2 and Bmi-1. Conclusions: Collectively, these data demonstrated that tumorspheres derived from PCa cells possess chemoresistant and CSC properties. Our study suggests that the identification of PCa CSCs could provide new insight into the lethal phenotype of PCa and therapeutic implications.

AB - Purpose: Prostate cancer (PCa) becomes lethal when cancer cells develop into castration-resistant PCa, which remains incurable because of the poor understanding of their cell origin and characteristics. We aim to investigate the potential role of cancer stem cells (CSCs) in PCa progression. Methods: Human PCa cell lines (LNCaP, 22RV1, DU145 and PC-3) were plated in serum-free suspension culture system allowed for tumorsphere forming. To evaluate the CSC characteristics of tumorspheres, the self-renewal, chemoresistance, tumorigenicity of the PCa tumorsphere cells, and the expression levels of stemness-related proteins in the PCa tumorsphere cells were assessed, comparing with the parental adherent cells. Results: Tumorsphere cells from PCa cell lines displayed enhanced self-renewal, chemoresistance and tumor-initiating capacity when compared with the adherent cells. Additionally, these cells overexpressed CSC marker CD44. Also, the tumorsphere cells expressed high levels of "stemness" genes Gli1, ABCG2 and Bmi-1. Conclusions: Collectively, these data demonstrated that tumorspheres derived from PCa cells possess chemoresistant and CSC properties. Our study suggests that the identification of PCa CSCs could provide new insight into the lethal phenotype of PCa and therapeutic implications.

KW - Cancer stem cell

KW - Chemoresistance

KW - Prostate cancer

KW - Stemness

KW - Tumorsphere

UR - http://www.scopus.com/inward/record.url?scp=84863100174&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863100174&partnerID=8YFLogxK

U2 - 10.1007/s00432-011-1146-2

DO - 10.1007/s00432-011-1146-2

M3 - Article

C2 - 22237455

AN - SCOPUS:84863100174

VL - 138

SP - 675

EP - 686

JO - Journal of Cancer Research and Clinical Oncology

JF - Journal of Cancer Research and Clinical Oncology

SN - 0171-5216

IS - 4

ER -